By John Harrington
Date: Friday 12 Mar 2010
Global pharmaceuticals leviathan GlaxoSmithKline has dumped the rest of its holding in former subsidiary Maxygen.
No recent information was found.
| Maxygen Shares Rise on Possible Deal | 23-May-2003 | LA Times |
| Maxygen teaming up with Roche | 23-May-2003 | BayArea.com |
No recent information was found.
No recent information was found.
| Currency | US Dollars |
| Share Price | $ 5.85 |
| Change Today | $ 0.02 |
| % Change | 0.34 % |
| 52 Week High | $6.20 |
| 52 Week Low | $5.21 |
| Volume | 39,160 |
| Shares Issued | 27.76m |
| Market Cap | $162.38m |
| Beta | 0.47 |
| RiskGrade | 104 |
| Time | Volume / Share Price |
| 16:00 | 5,897 @ $5.85 |
| 15:59 | 114 @ $5.85 |
| 15:59 | 100 @ $5.86 |
| 15:59 | 100 @ $5.85 |
| 15:59 | 100 @ $5.85 |
You are here: research